BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 33830112)

  • 41. Increased prevalence and risk of non-alcoholic fatty liver disease in overweight and obese patients with Type 2 diabetes in South China.
    Yi M; Chen RP; Yang R; Chen H
    Diabet Med; 2017 Apr; 34(4):505-513. PubMed ID: 27334577
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Phospholipid transfer protein activity is determined by type 2 diabetes mellitus and metabolic syndrome, and is positively associated with serum transaminases.
    Dullaart RP; de Vries R; Dallinga-Thie GM; Sluiter WJ; van Tol A
    Clin Endocrinol (Oxf); 2008 Mar; 68(3):375-81. PubMed ID: 17877759
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Liver Fat, Hepatic Enzymes, Alkaline Phosphatase and the Risk of Incident Type 2 Diabetes: A Prospective Study of 132,377 Adults.
    Chen SC; Tsai SP; Jhao JY; Jiang WK; Tsao CK; Chang LY
    Sci Rep; 2017 Jul; 7(1):4649. PubMed ID: 28680048
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Associations of coffee consumption with markers of liver injury in the insulin resistance atherosclerosis study.
    Dickson JC; Liese AD; Lorenzo C; Haffner SM; Watkins SM; Hamren SJ; Stiles JK; Wagenknecht LE; Hanley AJ
    BMC Gastroenterol; 2015 Jul; 15():88. PubMed ID: 26215323
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combination of Aspartate Aminotranferase and Tumor Necrosis Factor-α as Non Invasive Diagnostic Tools for Non Alcoholic Steatohepatitis (NASH).
    Purnomo HD; Mundhofir FE; Kasno ; Sudijanto E; Darmono ; Daldiyono ; Djokomoeljanto R; Faradz SM
    Acta Med Indones; 2015 Jan; 47(1):16-23. PubMed ID: 25948763
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Metabolic Syndrome and Serum Liver Enzymes Level at Patients with Type 2 Diabetes Mellitus.
    Music M; Dervisevic A; Pepic E; Lepara O; Fajkic A; Ascic-Buturovic B; Tuna E
    Med Arch; 2015 Aug; 69(4):251-5. PubMed ID: 26543313
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The association between the serum levels of uric acid and alanine aminotransferase in a population-based cohort.
    Zelber-Sagi S; Ben-Assuli O; Rabinowich L; Goldstein A; Magid A; Shalev V; Shibolet O; Chodick G
    Liver Int; 2015 Nov; 35(11):2408-15. PubMed ID: 25845417
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Insulin resistance and alanine amino transaminase (ALT) levels in first degree relatives of type 2 diabetes mellitus.
    Kuzhandai velu V; Jyothirmayi B; Kumar JS
    Diabetes Metab Syndr; 2011; 5(3):143-7. PubMed ID: 22813567
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of insulin resistance and adipocytokines on serum alanine aminotransferase in obese patients with type 2 diabetes mellitus.
    de Luis DA; Aller R; Izaola O; Gonzalez Sagrado M; Conde R; de la Fuente B
    Eur Rev Med Pharmacol Sci; 2013; 17(15):2059-64. PubMed ID: 23884827
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Increased liver markers are associated with higher risk of type 2 diabetes.
    Ko SH; Baeg MK; Han KD; Ko SH; Ahn YB
    World J Gastroenterol; 2015 Jun; 21(24):7478-87. PubMed ID: 26139993
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serum gamma-glutamyltransferase, alanine aminotransferase, and aspartate aminotransferase activity in Iranian healthy blood donor men.
    Khedmat H; Fallahian F; Abolghasemi H; Hajibeigi B; Attarchi Z; Alaeddini F; Holisaz MT; Pourali M; Sharifi S; Zarei N
    World J Gastroenterol; 2007 Feb; 13(6):889-94. PubMed ID: 17352018
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Analysis of metabolic risk factors for developing nonalcoholic fatty liver in patients with type 2 diabetes mellitus].
    Guo M; Xi G; Yang N; Yao H
    Zhonghua Gan Zang Bing Za Zhi; 2014 Aug; 22(8):631-5. PubMed ID: 25243967
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Salivary and Serum Aspartate Aminotransferases and Alanine Aminotransferases in Insulin-Dependent Diabetes Mellitus and Normal Children: A Comparative Study.
    Vinod KS; Madathil LP; Shetty P; Kaur H; Patel M; Gouraha A
    J Int Soc Prev Community Dent; 2018; 8(3):229-234. PubMed ID: 29911060
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Associations of White Blood Cell Count,Alanine Aminotransferase,and Aspartate Aminotransferase in the First Trimester withGestational Diabetes Mellitus.
    Zhao LL; Li W; Ping F; Ma LK; Nie M
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Jun; 38(3):283-7. PubMed ID: 27469912
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cross-sectional pilot study about the liver enzymes profile in type 2 diabetic patients from an Algerian west region: Wilaya of Mostaganem.
    Belkacemi L; Belalia M
    Diabetes Metab Syndr; 2016; 10(1 Suppl 1):S147-50. PubMed ID: 26711007
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Examining the Relationship Between Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome in Nondiabetic Subjects.
    Preuss HG; Kaats GR; Mrvichin N; Swaroop A; Bagchi D; Clouatre D; Preuss JM
    J Am Coll Nutr; 2018 Aug; 37(6):457-465. PubMed ID: 29652564
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Insulin resistance is associated with elevated transaminases and low aspartate aminotransferase/alanine aminotransferase ratio in young adults with normal weight.
    Simental-Mendía LE; Rodríguez-Morán M; Gómez-Díaz R; Wacher NH; Rodríguez-Hernández H; Guerrero-Romero F
    Eur J Gastroenterol Hepatol; 2017 Apr; 29(4):435-440. PubMed ID: 28009717
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Combined Non-alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: Sleeve Gastrectomy or Gastric Bypass?-a Controlled Matched Pair Study of 34 Patients.
    Billeter AT; Senft J; Gotthardt D; Knefeli P; Nickel F; Schulte T; Fischer L; Nawroth PP; Büchler MW; Müller-Stich BP
    Obes Surg; 2016 Aug; 26(8):1867-74. PubMed ID: 26660688
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Study on Liver Dysfunction in Type 2 Diabetic Patients in Bangladesh.
    Or Rashid MH; Haque MZ; Rahman MK; Mahbubur Rahman Khan M; Mahbubur Rahman ASM; Mamun-Al-Mahtab ; Rahman MS; Roy PK; Islam MN
    Euroasian J Hepatogastroenterol; 2016; 6(1):1-4. PubMed ID: 29201714
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Risk factors associated with nonalcoholic fatty liver disease and its relationship with the hepatic histological changes.
    Rodríguez-Hernández H; Gonzalez JL; Márquez-Ramirez MD; Flores-Hernandez M; Rodríguez-Morán M; Guerrero-Romero F
    Eur J Gastroenterol Hepatol; 2008 May; 20(5):399-403. PubMed ID: 18403941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.